News about Global Pharma

Asahi Kasei Bioprocess and Axolabs Forge Alliance to Propel Oligonucleotide Therapeutics

Oligonucleotide therapies offer a targeted approach to treating diseases by modulating gene expression, splicing, and protein production.

Global Pharma | 15/04/2024 | By Abha |  857

Awshad Rolls Out Brain-Boosting Nutritional Supplement Myndshroom

Awshad, a pioneering medical cannabis wellness startup, has rolled out its latest innovation, Myndshroom.

Global Pharma | 15/04/2024 | By Aishwarya |  1113

Thermo Fisher Introduces CTS OpTmizer One SFM to Boost Cell Therapy Manufacturing

Thermo Fisher Scientific has introduced the Gibco CTS OpTmizer One Serum-Free Medium (CTS OpTmizer One SFM).

Global Pharma | 15/04/2024 | By Aishwarya |  784

AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant for Preventive Treatment of Migraine

The overall long-term safety results were consistent with the known safety profile of atogepant in chronic and episodic migraine, and no new safety signals were identified.

Global Pharma | 12/04/2024 | By Manvi |  646

Telix Pharmaceuticals Completes Acquisition of ARTMS

Telix Pharmaceuticals Ltd. has completed the acquisition of ARTMS Inc.
<br />

Global Pharma | 12/04/2024 | By Aishwarya |  696

Corvia Medical Responds to Trial Data, Emphasizes Patient Selection in Heart Failure Therapy

This therapy is currently under investigation in the global RESPONDER-HF trial of the Corvia® Atrial Shunt.

Global Pharma | 12/04/2024 | By Abha |  557

Lamassu Biotech Receives FDA Approval for Phase 1/2a Clinical Trials of Novel Cancer Therapy

This approval paves the way for the initiation of Phase 1/2a clinical trials for SA53-OS, a therapy designed to combat locally advanced metastatic p53 wild-type tumors.

Global Pharma | 12/04/2024 | By Abha |  711

Orna Therapeutics Appoints Frank Neumann as CMO

Orna Therapeutics, a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA therapeutics (oRNA®) announced that Frank Neumann, M.D., Ph.D., will join the Company as Chief Medical Officer.

Global Pharma | 11/04/2024 | By Manvi |  569

Sen-Jam Pharmaceutical and KVK-Tech to Provide CMC for Anti-Inflammatory Injectable

Sen-Jam Pharmaceutical has entered a third strategic collaboration with KVK-Tech.

Global Pharma | 11/04/2024 | By Aishwarya |  1016

Vertex Signs Agreement to Acquire Alpine Immune Sciences

Vertex Pharmaceuticals has signed a definitive agreement with Alpine Immune Sciences, a biotechnology company focused on discovering and developing innovative, protein-based immunotherapies.

Global Pharma | 11/04/2024 | By Aishwarya |  917